SB 91 IN

0likes☆Favorite🔕SubscribeShare

Became Law

Prohibits a qualified entity that operates a syringe exchange program (program) from establishing or operating a fixed site for the distribution or exchange of a syringe or needle within 1,000 feet of specified facilities. Creates an exception. Allows the Indiana department of health to deny, suspend, or revoke a qualified entity's annual registration for a violation. Amends the duties of a qualified entity that operates a program. Establishes requirements for program participation. Prohibits a qualified entity that operates a program from providing chemical reagents or precursors. Requires the state health commissioner to investigate any complaint regarding a qualified entity's noncompliance with the qualified entity's duties concerning the operation of a program. Permits the state health commissioner to suspend or terminate the approval of a qualified entity for noncompliance. Extends the expiration of the program to July 1, 2031.

• Michael Crider Republican · author
• Ed Charbonneau Republican · author
• Brett Clark Republican · author
• Edward Clere Independent · sponsor

1. Dec 9, 2025 First reading: referred to Committee on Health and Provider Services · upper
2. Dec 9, 2025 Authored by Senator Crider · upper
3. Jan 8, 2026 Senator Yoder added as coauthor · upper
4. Jan 8, 2026 Senator Clark added as third author · upper
5. Jan 8, 2026 Committee report: do pass, adopted · upper
6. Jan 8, 2026 Senator Charbonneau added as second author · upper
7. Jan 12, 2026 Senator Walker K added as coauthor · upper
8. Jan 13, 2026 Senators Bohacek, Jackson L added as coauthors · upper
9. Jan 20, 2026 Senator Randolph added as coauthor · upper
10. Jan 26, 2026 Amendment #2 (Crider) prevailed; voice vote · upper
11. Jan 26, 2026 Second reading: amended, ordered engrossed · upper
12. Jan 27, 2026 Senator Pol added as coauthor · upper
13. Jan 27, 2026 House sponsor: Representative Clere · upper
14. Jan 27, 2026 Third reading: passed; Roll Call 93: yeas 33, nays 13 · upper
15. Jan 27, 2026 Cosponsors: Representatives Lawson, Goss-Reaves · upper
16. Jan 28, 2026 Representative Goss-Reaves removed as cosponsor · lower
17. Jan 28, 2026 Referred to the House · upper
18. Jan 29, 2026 First reading: referred to Committee on Public Health · lower
19. Feb 10, 2026 Committee report: amend do pass, adopted · lower
20. Feb 17, 2026 Amendment #12 (Ireland) prevailed; voice vote · lower
21. Feb 17, 2026 Amendment #14 (Clere) prevailed; voice vote · lower
22. Feb 17, 2026 Representatives Zimmerman, Garcia Wilburn added as cosponsors · lower
23. Feb 17, 2026 Second reading: amended, ordered engrossed · lower
24. Feb 17, 2026 Amendment #11 (Mayfield) prevailed; voice vote · lower
25. Feb 18, 2026 Third reading: passed; Roll Call 271: yeas 70, nays 22 · lower
26. Feb 19, 2026 Motion to concur filed · upper
27. Feb 19, 2026 Returned to the Senate with amendments · lower
28. Feb 25, 2026 Senate concurred with House amendments; Roll Call 273: yeas 38, nays 10 · upper
29. Feb 27, 2026 Signed by the President of the Senate · upper
30. Feb 27, 2026 Signed by the Speaker · lower
31. Mar 10, 2026 Bill Became Law on 8th Day Without Signature · upper
32. Feb 27, 2026 Signed by the President Pro Tempore · upper
33. Mar 10, 2026 Public Law 144 · upper